Molina Healthcare MOH
$198.39 −$4.95 (-2.43%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $199.59 +0.60%
Open$208.63
Prev close$203.34
Day range$197.25 – $213.68
Volume800.7K
Market cap$10.36B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$11.08B-3.4% YoY
Operating profit$106.00M-22.6% YoY
Net profit$38.00M-51.9% YoY
Diluted EPS$0.73-51.7% YoY
Free cash flow-$196.00M-20.2% YoY
Operating cash flow-$159.00M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin8.0%
Operating margin0.6%
Net margin-0.1%
Return on equity-1.2%
Return on assets-0.3%
Return on invested capital1.0%
Current ratio1.69
Liabilities / assets73.5%
Cash & investments$8.58B
Total debt$3.95B
Net cash (debt)$4.63B
Free cash flow / sales0.5%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $11.08B | $10.87B | $10.80B | $45.43B | $11.38B |
| Total Operating Revenue | $11.08B | $10.87B | $10.80B | $45.43B | $11.38B |
| Cost of Revenue | $10.22B | $9.95B | $9.77B | $41.35B | $10.67B |
| Gross Profit | $863.00M | $929.00M | $1.02B | $4.08B | $701.00M |
| Operating Expense | $757.00M | $784.00M | $846.00M | $3.29B | $863.00M |
| Selling and Admin Expenses | $710.00M | $724.00M | $779.00M | $3.01B | $795.00M |
| -General & Admin Expense | $710.00M | $724.00M | $779.00M | $3.01B | $795.00M |
| Depreciation & Amortization & Depletion | $38.00M | $40.00M | $39.00M | $195.00M | $44.00M |
| -Depreciation & Amortization | $38.00M | $40.00M | $39.00M | $195.00M | $44.00M |
| Other Operating Expenses | $9.00M | $20.00M | $28.00M | $90.00M | $24.00M |
| Operating Profit | $106.00M | $145.00M | $176.00M | $781.00M | -$162.00M |
| Net Non-Operating Interest Income (Expense) | -$53.00M | -$54.00M | -$54.00M | -$192.00M | -$52.00M |
| Non-Operating Interest Expense | $53.00M | $54.00M | $54.00M | $192.00M | $52.00M |
| Special Income (Charges) | $0.00 | $0.00 | -$93.00M | – | – |
| -Less:Write Off | $0.00 | $0.00 | $93.00M | – | – |
| Pretax Profit | $53.00M | $91.00M | $29.00M | $589.00M | -$214.00M |
| Tax | $15.00M | $31.00M | $15.00M | $117.00M | -$54.00M |
| Net Profit | $38.00M | $60.00M | $14.00M | $472.00M | -$160.00M |
| Profit from Continuing Operations | $38.00M | $60.00M | $14.00M | $472.00M | -$160.00M |
| Net Income to Parent Company | $38.00M | $60.00M | $14.00M | $472.00M | -$160.00M |
| Net Income to Common Stockholders | $38.00M | $60.00M | $14.00M | $472.00M | -$160.00M |
| Basic EPS | $0.74 | $1.19 | $0.27 | $8.93 | -$3.11 |
| Diluted EPS | $0.73 | $1.19 | $0.27 | $8.92 | -$3.15 |
| Other Income (Expense) | – | – | -$93.00M | – | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $15.65B | $16.00B | $16.39B | $15.56B | $15.56B |
| Total Current Assets | $12.51B | $12.93B | $13.33B | $12.44B | $12.44B |
| Cash and Cash Equivalents & Short-Term Investments | $8.58B | $8.92B | $9.25B | $8.26B | $8.26B |
| -Cash and Cash Equivalents | $4.48B | $4.99B | $5.31B | $4.25B | $4.25B |
| -Short Term Investments | $4.10B | $3.93B | $3.94B | $4.01B | $4.01B |
| Receivables | $3.36B | $3.49B | $3.42B | $3.53B | $3.53B |
| -Accounts Receivable | $3.36B | $3.49B | $3.42B | $3.53B | $3.53B |
| Other Current Assets | $576.00M | $528.00M | $655.00M | $655.00M | $655.00M |
| Total Non-Current Assets | $3.14B | $3.08B | $3.07B | $3.12B | $3.12B |
| Net PPE | $324.00M | $311.00M | $300.00M | $301.00M | $301.00M |
| Goodwill and Other Intangible Assets | $2.07B | $2.08B | $2.09B | $2.20B | $2.20B |
| Non-Current Deferred Assets | $267.00M | $229.00M | $215.00M | $178.00M | $178.00M |
| Other Non-Current Assets | $474.00M | $453.00M | $458.00M | $446.00M | $446.00M |
| Total Liabilities | $11.50B | $11.83B | $12.31B | $11.50B | $11.50B |
| Total Current Liabilities | $7.39B | $7.70B | $8.19B | $7.37B | $7.37B |
| Payables | $7.31B | $7.63B | $7.79B | $7.31B | $7.31B |
| -Accounts Payable | $1.18B | $1.14B | $1.16B | $1.09B | $1.09B |
| -Other Payable | $6.13B | $6.49B | $6.63B | $6.21B | $6.21B |
| Current Deferred Liabilities | $82.00M | $69.00M | $401.00M | $66.00M | $66.00M |
| Total Non-Current Liabilities | $4.10B | $4.13B | $4.12B | $4.12B | $4.12B |
| Long Term Debt and Capital Lease Obligation | $3.95B | $3.95B | $3.95B | $3.95B | $3.95B |
| -Long Term Debt | $3.77B | $3.77B | $3.77B | $3.77B | $3.77B |
| -Long Term Capital Lease Obligation | $179.00M | $184.00M | $180.00M | $184.00M | $184.00M |
| Other Non-Current Liabilities | $153.00M | $179.00M | $176.00M | $173.00M | $173.00M |
| Total Equity | $4.16B | $4.17B | $4.08B | $4.07B | $4.07B |
| Stockholders' Equity | $4.16B | $4.17B | $4.08B | $4.07B | $4.07B |
| Capital Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| -Common Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $536.00M | $511.00M | $471.00M | $452.00M | $452.00M |
| Retained Earnings | $3.71B | $3.68B | $3.62B | $3.60B | $3.60B |
| Gains/Losses Not Affecting Retained Earnings | -$95.00M | -$16.00M | -$7.00M | $15.00M | $15.00M |
| -Gross PPE | – | – | – | $1.18B | $1.18B |
| -Accumulated Depreciation | – | – | – | -$875.00M | -$875.00M |
| -Goodwill | – | – | – | $1.96B | $1.96B |
| -Other Intangible Assets | – | – | – | $237.00M | $237.00M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$159.00M | -$294.00M | $1.08B | -$535.00M | -$298.00M |
| Net cash flow from continuing operations | -$159.00M | -$294.00M | $1.08B | -$535.00M | -$298.00M |
| Net Income from Continuing Operations | $38.00M | $60.00M | $14.00M | $472.00M | -$160.00M |
| Depreciation & Depletion & Amortization | $38.00M | $40.00M | $39.00M | $195.00M | $44.00M |
| Deferred Tax | -$13.00M | -$11.00M | -$30.00M | $43.00M | $6.00M |
| Other Non-Cash Items | -$19.00M | – | – | -$3.00M | -$1.00M |
| Change in Working Capital | -$229.00M | -$407.00M | $933.00M | -$1.29B | -$207.00M |
| -Change in Receivables | $126.00M | -$65.00M | $113.00M | -$145.00M | -$27.00M |
| -Change in Prepaid Assets | $2.00M | $95.00M | -$86.00M | $52.00M | $77.00M |
| -Change in Payables and Accrued Expense | -$341.00M | -$147.00M | $492.00M | -$944.00M | -$125.00M |
| -Change In Other Working Capital | -$16.00M | -$290.00M | $414.00M | -$252.00M | -$132.00M |
| Net cash flow from investing | -$309.00M | -$30.00M | $11.00M | $312.00M | $230.00M |
| Net Cash Flow from Continuing Investing Activities | -$309.00M | -$30.00M | $11.00M | $312.00M | $230.00M |
| Net PPE Purchase and Sale | -$37.00M | -$30.00M | -$27.00M | -$101.00M | $1.00M |
| Net Business Purchase and Sale | $0.00 | $0.00 | $0.00 | -$245.00M | $0.00 |
| Net Investment Purchase and Sale | -$271.00M | $0.00 | $46.00M | $657.00M | $247.00M |
| Net Other Investing Changes | -$1.00M | $0.00 | -$8.00M | $1.00M | -$18.00M |
| Financing Cash Flow | -$7.00M | -$4.00M | -$20.00M | -$170.00M | $92.00M |
| Net Cash Flow from Continuing Financing Activities | -$7.00M | -$4.00M | -$20.00M | -$170.00M | $92.00M |
| Net Issuance Payments Of Debt | $0.00 | $0.00 | $0.00 | $838.00M | $98.00M |
| Net Common Stock Issuance | $0.00 | $0.00 | $0.00 | -$1.00B | $0.00 |
| Net Other Financing Charges | -$7.00M | -$4.00M | -$20.00M | -$8.00M | -$6.00M |
| Ending Cash Balance | $4.62B | $5.09B | $5.42B | $4.35B | $4.35B |
| Net Change in Cash | -$475.00M | -$328.00M | $1.07B | -$393.00M | $24.00M |
| Beginning Cash Balance | $5.09B | $5.42B | $4.35B | $4.74B | $4.32B |
| Free Cash Flow | -$196.00M | -$324.00M | $1.06B | -$636.00M | -$297.00M |
No comments yet — be the first to weigh in on MOH.
Sign in to join the discussion.